Somatostatin Receptor Imaging in NPC, EBV Related Cancers

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

July 17, 2025

Study Completion Date

July 17, 2025

Conditions
Nasopharyngeal CancerEpstein-Barr Virus Related Carcinoma
Interventions
RADIATION

FDG-PET

Patients will be fasted for 6 hours prior to intravenous injection of 370MBq +/- 10% (18)F-fluorodeoxyglucose. Scanning will be performed at an interval of at least 60 minutes following the injection.

RADIATION

Galium-68 DOTATATE

200MBq +/- 10% Galium-68 DOTATATE will be injected intravenously. Scanning will be performed approximately 60 minutes after the injection.

Trial Locations (1)

Unknown

National Cancer Centre Singapore, Singapore

All Listed Sponsors
collaborator

National Cancer Centre Research Fund

UNKNOWN

lead

National Cancer Centre, Singapore

OTHER

NCT05581550 - Somatostatin Receptor Imaging in NPC, EBV Related Cancers | Biotech Hunter | Biotech Hunter